Future COVID19 surges prediction based on SARS-CoV-2 mutations surveillance

  1. Fares Z Najar
  2. Evan Linde
  3. Chelsea L Murphy
  4. Veniamin A Borin
  5. Haun Wang
  6. Shozeb Haider
  7. Pratul K Agarwal  Is a corresponding author
  1. Oklahoma State University, United States
  2. University College London, United Kingdom

Abstract

COVID19 has aptly revealed that airborne viruses such as SARS-CoV-2 with the ability to rapidly mutate, combined with high rates of transmission and fatality can cause a deadly world-wide pandemic in a matter of weeks.1 Apart from vaccines and post-infection treatment options, strategies for preparedness will be vital in responding to the current and future pandemics. Therefore, there is wide interest in approaches that allow predictions of increase in infections ('surges') before they occur. We describe here real time genomic surveillance particularly based on mutation analysis, of viral proteins as a methodology for a priori determination of surge in number of infection cases. The full results are available for SARS-CoV-2 at http://pandemics.okstate.edu/covid19/, and are updated daily as new virus sequences become available. This approach is generic and will also be applicable to other pathogens.

Data availability

All sequences used in this work are available from GenBank. The protocol used for analysis are described in the supporting information.

The following previously published data sets were used

Article and author information

Author details

  1. Fares Z Najar

    High-Performance Computing Center, Oklahoma State University, Stillwater, United States
    Competing interests
    No competing interests declared.
  2. Evan Linde

    High-Performance Computing Center, Oklahoma State University, Stillwater, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2053-6721
  3. Chelsea L Murphy

    High-Performance Computing Center, Oklahoma State University, Stillwater, United States
    Competing interests
    No competing interests declared.
  4. Veniamin A Borin

    High-Performance Computing Center, Oklahoma State University, Stillwater, United States
    Competing interests
    No competing interests declared.
  5. Haun Wang

    School of Pharmacy, Pharmaceutical and Biological Chemistry, University College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  6. Shozeb Haider

    School of Pharmacy, Pharmaceutical and Biological Chemistry, University College London, London, United Kingdom
    Competing interests
    Shozeb Haider, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2650-2925
  7. Pratul K Agarwal

    1High-Performance Computing Center, Oklahoma State University, Stillwater, United States
    For correspondence
    pratul.agarwal@okstate.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3848-9492

Funding

No external funding was received for this work.

Copyright

© 2023, Najar et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,561
    views
  • 194
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Fares Z Najar
  2. Evan Linde
  3. Chelsea L Murphy
  4. Veniamin A Borin
  5. Haun Wang
  6. Shozeb Haider
  7. Pratul K Agarwal
(2023)
Future COVID19 surges prediction based on SARS-CoV-2 mutations surveillance
eLife 12:e82980.
https://doi.org/10.7554/eLife.82980

Share this article

https://doi.org/10.7554/eLife.82980

Further reading

    1. Epidemiology and Global Health
    2. Genetics and Genomics
    Tianyu Zhao, Hui Li ... Li Chen
    Research Article

    Alzheimer’s disease (AD) is a complex degenerative disease of the central nervous system, and elucidating its pathogenesis remains challenging. In this study, we used the inverse-variance weighted (IVW) model as the major analysis method to perform hypothesis-free Mendelian randomization (MR) analysis on the data from MRC IEU OpenGWAS (18,097 exposure traits and 16 AD outcome traits), and conducted sensitivity analysis with six models, to assess the robustness of the IVW results, to identify various classes of risk or protective factors for AD, early-onset AD, and late-onset AD. We generated 400,274 data entries in total, among which the major analysis method of the IVW model consists of 73,129 records with 4840 exposure traits, which fall into 10 categories: Disease, Medical laboratory science, Imaging, Anthropometric, Treatment, Molecular trait, Gut microbiota, Past history, Family history, and Lifestyle trait. More importantly, a freely accessed online platform called MRAD (https://gwasmrad.com/mrad/) has been developed using the Shiny package with MR analysis results. Additionally, novel potential AD therapeutic targets (CD33, TBCA, VPS29, GNAI3, PSME1) are identified, among which CD33 was positively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. TBCA and VPS29 were negatively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. GNAI3 and PSME1 were negatively associated with the main outcome traits of AD, as well as with LOAD, but had no significant causal association with EOAD. The findings of our research advance our understanding of the etiology of AD.

    1. Epidemiology and Global Health
    Xiaoning Wang, Jinxiang Zhao ... Dong Liu
    Research Article

    Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. We have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the ECs in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that reduced foxo1a mediated the excessive angiogenesis induced by monosaccharides via upregulating the expression of marcksl1a. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.